1.
Byrgazov K, Lucini CB, Valent P, Hantschel O, Lion T. BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib. Haematologica 2017; 103(1):e10-e12; https://doi.org/10.3324/haematol.2017.176347.